Intensive Care News and Research

RSS

Existing drug shows potential to revive immune cells in sepsis patients

When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, bacteria, or fungi.

18 Apr 2025

Covid worsened shortages of doctors and nurses. Five years on, rural hospitals still struggle.

Even by rural hospital standards, Keokuk County Hospital and Clinics in southeastern Iowa is small.

18 Apr 2025

New Cochrane review highlights gaps in newborn pain assessment tools

A newly-published Cochrane review reveals significant gaps in the clinical rating scales used to assess pain in newborn babies, highlighting the urgent need for improved tools and global collaboration.

14 Apr 2025

RSV-associated infections linked to higher one year mortality in adults

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one year compared to the general population.

11 Apr 2025

IL-6 emerges as early sepsis indicator in high risk groups

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women.

11 Apr 2025

Cholera cases in Europe linked to holy water imported from Ethiopia

Consumption of holy water from Ethiopia has recently led to several cases of cholera in Germany and the United Kingdom (UK) with a multidrug-resistant Vibrio cholerae strain, according to a study published in Eurosurveillance.

10 Apr 2025

Exploring the complex association between anemia and retinopathy of prematurity

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP).

10 Apr 2025

Oklahoma Children's Hospital improves care for babies with neonatal abstinence syndrome

In years past, health care providers took a punitive stance toward women giving birth to babies exposed to substances like opioids in the womb.

9 Apr 2025

Rural hospitals and patients are disconnected from modern care

Leroy Walker arrived at the county hospital short of breath. Walker, 65 and with chronic high blood pressure, was brought in by one of rural Greene County’s two working ambulances.

9 Apr 2025

Global research initiative aims to optimize post-cardiac arrest ICU care

Researchers at 60 different intensive care units around the world are seeking to establish methods to expedite and improve post-cardiac arrest recovery at ICUs.

8 Apr 2025

New study reveals hidden spread of C. diff in intensive care units

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found.

4 Apr 2025

New AI system enhances nurse-driven patient monitoring and saves lives

An AI tool that analyzes nurses' data and notes detected when patients in the hospital were deteriorating nearly two days earlier than traditional methods and reduced the risk of death by over 35%, found a year-long clinical trial of more than 60,000 patients led by researchers at Columbia University.

2 Apr 2025

The evolution of OCT for retinal imaging and disease intervention

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the future of ophthalmic diagnostics.

From Avantier Inc. 1 Apr 2025

WINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) by 76% compared to placebo in the phase 3 ZENITH trial

Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR™ (sotatercept-csrk) compared to placebo in adults with pulmonary arterial hypertension (PAH, Group 1 PH) WHO* functional class (FC) III or IV at high risk of mortality who were on maximum tolerated background PAH therapy. At a median follow-up of 10.6 months (range, 0.3-26.1), WINREVAIR reduced the relative risk of major morbidity and mortality events (the composite of all-cause death, lung transplantation and PAH worsening-related hospitalization of ≥24 hours) by 76% (HR=0.24 [95% CI, 0.13-0.43]; p<0.0001 [1-sided]) compared to placebo.

1 Apr 2025

Vitamin D monitoring during pregnancy and postpartum

Researchers determine the impact of vitamin D levels during pregnancy and their role in maternal and infant health outcomes.

1 Apr 2025

Study finds no benefit of early IABP use in cardiogenic shock patients

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart failure did not improve 60-day survival or enable more patients to successfully transition to long-term treatment, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in JACC

31 Mar 2025

Pulse oximeter accuracy varies across skin pigment groups

The differences, or bias, between estimates of blood oxygen saturation levels as measured with pulse oximeters compared to the gold-standard method of measuring oxygen saturation in arterial blood varied significantly between patients with darkly pigmented skin compared to lighter skin pigment, according to research presented at the American College of Cardiology's Annual Scientific Session.

31 Mar 2025